Schroder Investment Management Group’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$58.2M Buy
295,035
+37,655
+15% +$7.32M 0.05% 283
2025
Q4
$45.2M Sell
257,380
-57,065
-18% -$10.4M 0.03% 332
2025
Q3
$59.4M Sell
314,445
-39,334
-11% -$6.98M 0.05% 266
2025
Q2
$63.5M Buy
353,779
+122,646
+53% +$21.3M 0.05% 244
2025
Q1
$38.7M Buy
231,133
+153,817
+199% +$25.3M 0.04% 342
2024
Q4
$11.7M Buy
77,316
+5,974
+8% +$929K 0.01% 630
2024
Q3
$11M Buy
71,342
+50,565
+243% +$7.55M 0.01% 644
2024
Q2
$2.84M Buy
20,777
+1,540
+8% +$211K ﹤0.01% 886
2024
Q1
$2.56M Sell
19,237
-1,243
-6% -$161K ﹤0.01% 890
2023
Q4
$2.82M Sell
20,480
-7,099
-26% -$933K ﹤0.01% 862
2023
Q3
$3.36M Sell
27,579
-70,321
-72% -$9.37M 0.01% 834
2023
Q2
$13.8M Sell
97,900
-31,320
-24% -$4.32M 0.02% 555
2023
Q1
$18.3M Sell
129,220
-11,632
-8% -$1.66M 0.03% 493
2022
Q4
$22M Sell
140,852
-169,495
-55% -$24.4M 0.04% 435
2022
Q3
$38.1M Sell
310,347
-680
-0.2% -$89.6K 0.06% 299
2022
Q2
$41.4M Sell
311,027
-25,784
-8% -$3.51M 0.06% 296
2022
Q1
$46.8M Sell
336,811
-140,854
-29% -$19.6M 0.06% 302
2021
Q4
$82.6M Buy
477,665
+28,000
+6% +$4.26M 0.11% 201
2021
Q3
$65.3M Buy
449,665
+379,107
+537% +$55.5M 0.1% 215
2021
Q2
$9.31M Buy
70,558
+3,389
+5% +$444K 0.01% 692
2021
Q1
$8.62M Sell
67,169
-421,480
-86% -$51.9M 0.01% 703
2020
Q4
$58.2M Sell
488,649
-310,408
-39% -$37.8M 0.08% 244
2020
Q3
$91M Buy
799,057
+322,894
+68% +$38.1M 0.15% 129
2020
Q2
$54.3M Buy
476,163
+18,928
+4% +$2.01M 0.1% 211
2020
Q1
$36M Sell
457,235
-506,080
-53% -$52.4M 0.08% 266
2019
Q4
$103M Sell
963,315
-656,387
-41% -$68.5M 0.17% 125
2019
Q3
$171M Sell
1,619,702
-82,559
-5% -$8.48M 0.3% 74
2019
Q2
$173M Buy
1,702,261
+238,525
+16% +$22.9M 0.32% 70
2019
Q1
$132M Buy
1,463,736
+325,379
+29% +$28.2M 0.23% 91
2018
Q4
$94.8K Buy
1,138,357
+843,661
+286% +$79.1M 0.17% 118
2018
Q3
$31.8M Sell
294,696
-148,245
-33% -$16.3M 0.05% 368
2018
Q2
$48.8M Sell
442,941
-76,144
-15% -$7.93M 0.09% 278
2018
Q1
$52.1M Sell
519,085
-16,497
-3% -$1.69M 0.09% 274
2017
Q4
$52.7M Sell
535,582
-55,262
-9% -$5.24M 0.09% 283
2017
Q3
$54.3M Buy
590,844
+10,102
+2% +$1.07M 0.09% 266
2017
Q2
$64.2M Sell
580,742
-1,607,372
-73% -$170M 0.12% 230
2017
Q1
$215M Buy
2,188,114
+167,246
+8% +$15.9M 0.39% 46
2016
Q4
$186M Sell
2,020,868
-757,935
-27% -$65.3M 0.36% 56
2016
Q3
$235M Buy
2,778,803
+257,003
+10% +$21.6M 0.44% 45
2016
Q2
$205M Buy
2,521,800
+980,063
+64% +$74.6M 0.41% 51
2016
Q1
$111M Buy
1,541,737
+40,837
+3% +$2.74M 0.23% 109
2015
Q4
$107M Sell
1,500,900
-348,571
-19% -$23.4M 0.22% 112
2015
Q3
$114M Sell
1,849,471
-413,800
-18% -$28.9M 0.24% 107
2015
Q2
$161M Buy
2,263,271
+1,769,300
+358% +$131M 0.32% 81
2015
Q1
$37.6M Buy
493,971
+306,893
+164% +$22M 0.07% 321
2014
Q4
$12.5M Sell
187,078
-1,674,229
-90% -$106M 0.02% 592
2014
Q3
$113M Sell
1,861,307
-362,861
-16% -$22.4M 0.15% 136
2014
Q2
$131M Buy
2,224,168
+10,900
+0.5% +$638K 0.16% 125
2014
Q1
$128M Buy
2,213,268
+376,547
+21% +$20.2M 0.14% 130
2013
Q4
$98.3M Sell
1,836,721
-268,900
-13% -$15.9M 0.12% 146
2013
Q3
$130M Sell
2,105,621
-382,080
-15% -$22.9M 0.32% 79
2013
Q2
$151M Buy
+2,487,701
New +$148M 0.4% 59

Other funds holding DGX

Schroder Investment Management Group's DGX Position: Q1 2026 in Review

Schroder Investment Management Group increased its Quest Diagnostics (DGX) stake by 15% in Q1 2026, buying an estimated $7.32M and bringing the position to 295,035 shares worth $58.2M. The position accounts for 0.05% of the portfolio, ranked #283.

Schroder Investment Management Group first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $235M in Q3 2016. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Schroder Investment Management Group held 295,035 shares of Quest Diagnostics worth $58.2M as of Q1 2026.
  • Schroder Investment Management Group bought 37,655 Quest Diagnostics shares in Q1 2026, an estimated $7.32M.
  • Quest Diagnostics made up 0.05% of Schroder Investment Management Group's portfolio in Q1 2026, its #283 holding.
  • Schroder Investment Management Group first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Schroder Investment Management Group's Quest Diagnostics position peaked at $235M in Q3 2016.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Schroder Investment Management Group's 13F filing for Q1 2026, filed 14 May 2026.